Page last updated: 2024-09-03

omega-n-methylarginine and Cerebrovascular Moyamoya Disease

omega-n-methylarginine has been researched along with Cerebrovascular Moyamoya Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, M; Kajita, Y; Kimura, M; Mizutani, N; Seki, Y; Suzuki, Y; Takayasu, M1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Cerebrovascular Moyamoya Disease

ArticleYear
Role of nitric oxide in the control of cerebral microcirculation under physiological and pathological conditions.
    Clinical hemorheology and microcirculation, 2000, Volume: 23, Issue:2-4

    Topics: Animals; Antioxidants; Arginine; Arterioles; Cerebral Revascularization; Cerebrovascular Circulation; Collateral Circulation; Dose-Response Relationship, Drug; Humans; Male; Microcirculation; Moyamoya Disease; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vasoconstrictor Agents; Vasomotor System

2000